The goal of this presentation is for attendees to be able to discuss the role of liver transplantation for hepatocellular carcinoma (HCC) and identify the risk factors, screening paradigms for HCC, barriers to liver transplantation, and survival outcomes for patients with HCC.

Learning Objectives
At the end of this educational activity, participants should be able to

1. Describe the epidemiology and risk factors for development of hepatocellular carcinoma (HCC)
2. Identify the appropriate screening protocols for HCC in high-risk cohorts
3. Recognize the classic radiographic appearance of HCC on cross-sectional imaging
4. Review the indications for liver transplant as oncologic treatment of HCC including the Milan Criteria (HCC size/ number acceptable for liver transplantation)
5. State the rational for “bridging therapy” for HCC patients awaiting liver transplantation
6. Compare survival of HCC patients following liver transplantation vs. all other treatment options (surgical resection, locoregional therapy, systemic chemotherapy)

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:

• Completing the entire activity
• Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Begin by clicking Take Course and viewing the CE Info; then follow the prompts at the bottom of the screen. At the end of the activity you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found in your profile.

Faculty Listing
Derek A. DuBay, MD
Assistant Professor of Surgery
Liver Transplant and Hepatobiliary Surgery
University of Alabama at Birmingham
UAB Health System, Division of Transplantation
Birmingham, Alabama

Faculty Disclosure
As a sponsor accredited by the ACCME, OptumHealth Education requires the disclosure of all relevant financial relationships a faculty member has with any commercial interest. The faculty reported the following:
Dr DuBay has indicated that she/he has received financial or material support from Onyx Pharma.
Dr Dubay does not intend to discuss unapproved/investigative use of commercial products/devices.

Staff Disclosures
In compliance with the ACCME's Standards for Commercial Support, employees of OptumHealth Education who have control over content of an activity are required to disclose their relevant financial relationships. No employee has a relevant financial relationship regarding this activity.

Activity Planners
Rebecca Gleason, RN, CCM
Manager, Clinical Programs
OptumHealth Education

Barbara Lindberg, JD, RN
Lead Nurse Planner
OptumHealth Education

Reviewer Disclosures
To ensure fair balance and avoid bias, the content for this activity has been reviewed by an independent medical expert with no relevant financial relationships and has been approved by OptumHealth Education.

Sponsored By
This activity is sponsored by OptumHealth Education.

Commercial Support
There was no commercial support received for this activity.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software.